BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2760199)

  • 1. Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury.
    Eidt JF; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
    J Clin Invest; 1989 Aug; 84(2):517-27. PubMed ID: 2760199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane A2 and serotonin mediate coronary blood flow reductions in unsedated dogs.
    Eidt JF; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
    Am J Physiol; 1989 Sep; 257(3 Pt 2):H873-82. PubMed ID: 2782444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury.
    Willerson JT; Eidt JF; McNatt J; Yao SK; Golino P; Anderson HV; Buja LM
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):101B-110B. PubMed ID: 2016468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo.
    Golino P; Buja LM; Yao SK; McNatt J; Willerson JT
    J Am Coll Cardiol; 1990 Mar; 15(3):718-26. PubMed ID: 2105989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.
    Ashton JH; Ogletree ML; Michel IM; Golino P; McNatt JM; Taylor AL; Raheja S; Schmitz J; Buja LM; Campbell WB
    Circulation; 1987 Oct; 76(4):952-9. PubMed ID: 3652429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators.
    Golino P; Ashton JH; Buja LM; Rosolowsky M; Taylor AL; McNatt J; Campbell WB; Willerson JT
    Circulation; 1989 Jan; 79(1):154-66. PubMed ID: 2910540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
    Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
    Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries.
    Ashton JH; Golino P; McNatt JM; Buja LM; Willerson JT
    J Am Coll Cardiol; 1989 Mar; 13(3):755-63. PubMed ID: 2521875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
    Apprill P; Schmitz JM; Campbell WB; Tilton G; Ashton J; Raheja S; Buja LM; Willerson JT
    Circulation; 1985 Aug; 72(2):397-405. PubMed ID: 2988822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.
    Eidt JF; Allison P; Noble S; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
    J Clin Invest; 1989 Jul; 84(1):18-27. PubMed ID: 2661588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT
    Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined ADP and thromboxane A2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in nonhuman primates.
    Yao SK; McNatt J; Cui K; Anderson HV; Maffrand JP; Buja LM; Willerson JT
    Circulation; 1993 Dec; 88(6):2888-93. PubMed ID: 8252702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial cellular alterations during myocardial ischemia and evolving infarction.
    Willerson JT; Buja LM
    Postgrad Med; 1988 Feb; Spec No():69-75. PubMed ID: 2894662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries.
    Ashton JH; Benedict CR; Fitzgerald C; Raheja S; Taylor A; Campbell WB; Buja LM; Willerson JT
    Circulation; 1986 Mar; 73(3):572-8. PubMed ID: 2936531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the role of thromboxane A2 and serotonin in the pathogenesis of unstable angina.
    Machado AP; Saavedra JA; Ribeiro C
    Rev Port Cardiol; 1994 Dec; 13(12):935-46, 893. PubMed ID: 7873224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries.
    Yao SK; Ober JC; Gonenne A; Clubb FJ; Krishnaswami A; Ferguson JJ; Anderson HV; Gorecki M; Buja LM; Willerson JT
    Circ Res; 1993 Nov; 73(5):952-67. PubMed ID: 8403265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
    Yao SK; Benedict CR; Rosolowsky M; McNatt J; Falinska B; Campbell WB; Buja LM; Willerson JT
    J Mol Cell Cardiol; 1991 Apr; 23(4):473-82. PubMed ID: 1942081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
    Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury.
    Willerson JT; Yao SK; McNatt J; Benedict CR; Anderson HV; Golino P; Murphree SS; Buja LM
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10624-8. PubMed ID: 1961728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.